Can the immediate‑release Robinul (clorazepate) tablets be crushed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Robinul Tablets Be Crushed?

There is no specific information in the FDA labeling for Robinul (glycopyrrolate) immediate-release tablets regarding crushing, and based on the drug's properties as a simple immediate-release anticholinergic without special formulation features, crushing appears to be a reasonable option when necessary for patients unable to swallow whole tablets.

Key Considerations

FDA Labeling Information

  • The Robinul FDA label provides detailed information about the injectable formulation but does not include specific instructions prohibiting or permitting crushing of the oral immediate-release tablets 1.
  • The absence of crushing restrictions in the labeling, combined with the drug's straightforward formulation, suggests no inherent pharmaceutical barrier to crushing 1.

Risk Assessment Framework

When evaluating crushability of immediate-release tablets, several factors must be considered 2, 3:

  • Special dosage form design: Robinul immediate-release tablets are not extended-release, enteric-coated, or sublingual formulations that would be compromised by crushing 2.
  • Hazardous drug status: Glycopyrrolate is not classified as a hazardous medication requiring special handling precautions during manipulation 3.
  • Stability concerns: As a quaternary ammonium anticholinergic, glycopyrrolate is relatively stable and does not have significant degradation issues with brief exposure to light or moisture during immediate administration 3.

Clinical Context

  • For patients with swallowing difficulties (dysphagia), crushing tablets and suspending in water for immediate administration is a common clinical practice 4.
  • The key is to administer the crushed medication immediately after preparation (within 2 hours) to minimize any potential stability concerns 2.

Practical Recommendations

If crushing Robinul tablets becomes necessary:

  • Crush the tablet using a mortar and pestle or commercial pill crusher 2.
  • Suspend the crushed powder in a small amount of plain water at room temperature 2.
  • Administer the suspension immediately (ideally within 15-30 minutes, maximum 2 hours) 2, 3.
  • Rinse the container with additional water and have the patient consume to ensure complete dose delivery 4.
  • Monitor for therapeutic effect, as crushing may slightly alter absorption kinetics 4.

Important Caveats

  • This recommendation applies specifically to immediate-release Robinul tablets only, not to any extended-release or specially formulated products 2.
  • Healthcare providers should always verify the specific product formulation before crushing 3.
  • When possible, consider alternative dosage forms such as the injectable formulation if the oral route is consistently problematic 1.
  • The person crushing tablets should use standard precautions to minimize dust exposure, though glycopyrrolate does not carry specific hazardous drug warnings 3, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.